Zantac | eHealth News

All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen

FDA Pulls Heartburn Drug Zantac From Market

HealthDay.com - Apr 1, 2020

Withdrawal of ranitidine products means they will not be available either by prescription or OTC

The U.S. Food and Drug Administration is adding to a list of recalled lots of popular heartburn medications -- including generic forms of Zantac -- because the pills might contain small amounts of the suspected carcinogen N-nitrosodimethylamine.

Two More Heartburn Meds Recalled Due to Possible Carcinogen

HealthDay.com - Jan 10, 2020

One California lab claims heat is raising NDMA levels in ranitidine tablets

The over-the-counter heartburn drug Zantac (ranitidine) has been recalled in the United States and Canada by French drug maker Sanofi.

Zantac Recalled by Sanofi

HealthDay.com - Oct 21, 2019

FDA has warned that some versions of the drug contain low levels of N-nitrosodimethylamine

CVS is the latest drugstore chain to stop selling over-the-counter Zantac (ranitidine)

CVS Halts Sales of OTC Zantac

HealthDay.com - Sep 30, 2019

Tests have found low levels of the nitrosamine impurity NDMA in some ranitidine products

Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen

HealthDay.com - Sep 19, 2019

Preliminary tests revealed low levels of the nitrosamine impurity NDMA in some ranitidine products

Archives